Organovo fiscal 2015 CF Ops down 26%; exVive3D sales almost $300K

|About: Organovo Holdings, Inc. (ONVO)|By:, SA News Editor

Organovo (NYSEMKT:ONVO) fiscal 2015 results ($M): Total Revenues: 0.6 (+50.7%); Product & Service Revenue: 0.3 (999%); Operating Expenses: 30.9 (+47.1%); Net Loss: (30.1) (-16.4%); Quick Assets: 50.1 (+3.9%); CF Ops: (19.6) (-26.0%).

ExVive3D Human Liver Tissue sales in fiscal 2015: $0.29M. Bookings from April 1, 2014 to June 9, 2015: $1.94M.

Subscribe for full text news in your inbox